PCSK9 inhibitor added to high-intensity statin therapy to prevent cardiovascular events in patients with acute coronary syndrome after percutaneous coronary intervention: a randomized, double- blind, placebo-controlled, multicenter SHAWN study
Titel:
PCSK9 inhibitor added to high-intensity statin therapy to prevent cardiovascular events in patients with acute coronary syndrome after percutaneous coronary intervention: a randomized, double- blind, placebo-controlled, multicenter SHAWN study
Auteur:
Wu, Zhi-Ming Kan, Jing Ye, Fei You, Wei Wu, Xiang-Qi Tian, Nai-Liang Lin, Song Ge, Zhen Liu, Zhi-Zhong Li, Xiao-Bo Gao, Xiao-Fei Chen, Jing Wang, Yan Wen, Shang-Yu Xie, Ping Cong, Hong-Liang Liu, Li-Jun Zeng, He-Song Zhou, Lei Liu, Fan Zheng, Yong-Hong Li, Rui Ji, Hong-Lei Zhou, Sheng-Hua Zhao, Shou-Ming Qian, Xue-Song Luo, Jun Wang, Xin Zhang, Jun-Jie Chen, Shao-Liang